Atomwise develops machine learning-based discovery engines and uses artificial intelligence (AI)-based neural networks to help discover new medicines. It predicts drug candidates for pharmaceutical companies, start-ups, and research institutions, and designs drugs using computational drug design. It was formerly known as Chematria. The company was founded in 2012 and is based in San Francisco, California.

Canomiks is a technology company focused on the functional food, beverage, dietary supplement, and cosmeceutical industries. The company offers a genomics and AI-based platform that develops new formulations and assesses the biological efficacy and safety of ingredients and formulations. Canomiks serves the functional food and beverage, dietary supplement, and skincare industries. It was founded in 2016 and is based in Rochester, Minnesota.

Rockfish Bio focuses on the development of senolytic therapies within the biotechnology sector. The company's main offerings include compounds designed to treat age-related diseases by targeting and eliminating senescent cells to promote healthy aging. Rockfish Bio's therapies are applicable to a range of conditions such as chronic kidney disease, liver fibrosis, and neurodegenerative diseases. It was founded in 2021 and is based in Wien, Austria.

Viome operates as a health and longevity company. It specializes in preventing, diagnosing, and reversing chronic diseases and aging through its at-home health tests and personalized nutrition. The company's main offerings include at-home microbiome health tests that utilize advanced RNA sequencing technology to generate health scores and nutrition recommendations tailored to an individual's unique biology. It was founded in 2016 and is based in Bellevue, Washington.

Indena is a company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and cosmetics industries. Indena, a privately owned Italian company, has around 700 employees, including 10% dedicated to full-time research, aims to manage cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. The phyto-chemical research is carried out in Indena's own Research Center in Settala, Italy. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. One of the main strategic objectives of the research is the development of new active principles for pharmaceutical applications. This is also an indispensable base for the health-food and cosmetics industries. In the pharmaceutical sector Indena is currently focusing on the development of anti-cancer treatments, following the successes of paclitaxel, as well as on anti-microbial and on anti-viral drugs. Also under study are active principles for the treatment of pathologies and dysfunction of the central nervous system, such as depression, anxiety, impotence, sleep disorders, and algesia. Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

Onegevity is a consumer health intelligence company, which combines a multi-omic AI platform with consumer-friendly products and digital services. The Health Intelligence platform can accept inputs from lab work, wearables, test results, clinical intake data, and virtually any other health and wellness information. From there, it uses AI to “map” the complex and dynamic metabolic outputs from an individual and compare to individuals alike. It can provide personalized lifestyle recommendations including nutrition, supplements, exercise/lifestyle, and can further recommend individualized follow-up testing, educational needs, and more. The platform can be used by an individual, a health-care practitioner, or for corporate wellness purposes.